Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Clinical outcome of implantable cardioverter defibrillators with recalled and non-recalled leads in Japanese patients. Increased failure rate of the Sprint Fidelis lead.

Yanagisawa S, Inden Y, Shimano M, Yoshida N, Ichiyanagi H, Fujita M, Ohguchi S, Ishikawa S, Kato H, Okumura S, Miyoshi A, Nagao T, Yamamoto T, Hirai M, Murohara T.

Circ J. 2014;78(2):353-9. Epub 2013 Nov 22.

2.

Class I recall of defibrillator leads: a comparison of the Sprint Fidelis and Riata families.

Liu J, Brumberg G, Rattan R, Jain S, Saba S.

Heart Rhythm. 2012 Aug;9(8):1251-5. doi: 10.1016/j.hrthm.2012.04.003. Epub 2012 Apr 3.

PMID:
22484652
3.

Transvenous extraction of implantable cardioverter-defibrillator leads under advisory--a comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads.

Brunner MP, Cronin EM, Jacob J, Duarte VE, Tarakji KG, Martin DO, Callahan T, Borek PP, Cantillon DJ, Niebauer MJ, Saliba WI, Kanj M, Wazni O, Baranowski B, Wilkoff BL.

Heart Rhythm. 2013 Oct;10(10):1444-50. doi: 10.1016/j.hrthm.2013.06.021. Epub 2013 Jun 28.

PMID:
23816440
4.

Comparison of Sprint Fidelis and Riata defibrillator lead failure rates.

Fazal IA, Shepherd EJ, Tynan M, Plummer CJ, McComb JM.

Int J Cardiol. 2013 Sep 30;168(2):848-52. doi: 10.1016/j.ijcard.2012.10.015. Epub 2012 Nov 6.

PMID:
23138013
5.

Clinical outcomes in patients with implantable cardioverter defibrillators and Sprint Fidelis leads.

Verlato R, Facchin D, Catanzariti D, Molon G, Zanotto G, Morani G, Brieda M, Zanon F, Delise P, Leoni L, Comisso J, Campo C.

Heart. 2013 Jun;99(11):799-804. doi: 10.1136/heartjnl-2012-303259. Epub 2013 Feb 22.

PMID:
23434626
6.

Update on small-diameter implantable cardioverter-defibrillator leads performance.

van Rees JB, van Welsenes GH, Borleffs CJ, Thijssen J, van der Velde ET, van der Wall EE, van Erven L, Schalij MJ.

Pacing Clin Electrophysiol. 2012 Jun;35(6):652-8. doi: 10.1111/j.1540-8159.2011.03338.x. Epub 2012 Feb 21.

PMID:
22352338
7.

Failure of implantable cardioverter-defibrillator leads: a matter of lead size?

Rordorf R, Poggio L, Savastano S, Vicentini A, Petracci B, Chieffo E, Klersy C, Landolina M.

Heart Rhythm. 2013 Feb;10(2):184-90. doi: 10.1016/j.hrthm.2012.10.017. Epub 2012 Oct 11.

PMID:
23063430
9.

Increasing hazard of Sprint Fidelis implantable cardioverter-defibrillator lead failure.

Hauser RG, Hayes DL.

Heart Rhythm. 2009 May;6(5):605-10. doi: 10.1016/j.hrthm.2009.02.024. Epub 2009 Feb 20.

PMID:
19285920
10.

Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age.

Girerd N, Nonin E, Pinot J, Morel E, Flys C, Scridon A, Chevalier P.

Arch Cardiovasc Dis. 2011 Jun-Jul;104(6-7):388-95. doi: 10.1016/j.acvd.2011.05.002. Epub 2011 Jul 8.

11.

Time-dependent risk of Fidelis lead failure.

Faulknier BA, Traub DM, Aktas MK, Aguila A, Rosero S, Daubert JP, Hall B, Shah A, Taylor S, McNitt S, Moss AJ, Zareba W, Huang DT.

Am J Cardiol. 2010 Jan 1;105(1):95-9. doi: 10.1016/j.amjcard.2009.08.655.

PMID:
20102898
12.

Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.

Hauser RG, Maisel WH, Friedman PA, Kallinen LM, Mugglin AS, Kumar K, Hodge DO, Morrison TB, Hayes DL.

Circulation. 2011 Feb 1;123(4):358-63. doi: 10.1161/CIRCULATIONAHA.110.975219. Epub 2011 Jan 17.

13.

Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead.

Morrison TB, Rea RF, Hodge DO, Crusan D, Koestler C, Asirvatham SJ, Bradley D, Shen WK, Munger TM, Hammill SC, Friedman PA.

J Cardiovasc Electrophysiol. 2010 Jun 1;21(6):671-7. doi: 10.1111/j.1540-8167.2009.01683.x. Epub 2010 Jan 15.

PMID:
20082653
14.

Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead.

Hauser RG, Kallinen LM, Almquist AK, Gornick CC, Katsiyiannis WT.

Heart Rhythm. 2007 Jul;4(7):892-6. Epub 2007 Apr 10.

PMID:
17599673
15.

Increased rate of subacute lead complications with small-caliber implantable cardioverter-defibrillator leads.

Ellis CR, Rottman JN.

Heart Rhythm. 2009 May;6(5):619-24. doi: 10.1016/j.hrthm.2009.02.020. Epub 2009 Feb 14.

PMID:
19389648
16.

Longitudinal follow-up of implantable cardioverter defibrillator leads.

Liu J, Brumberg G, Rattan R, Patel D, Adelstein E, Jain S, Saba S.

Am J Cardiol. 2014 Jan 1;113(1):103-6. doi: 10.1016/j.amjcard.2013.08.046. Epub 2013 Oct 6.

PMID:
24176060
17.

Trends in Fidelis lead survival: transition from an exponential to linear pattern of lead failure over time.

Cheung JW, Tobin-Hess A, Patel A, Slotwiner DJ, Goldner BG.

Circ Arrhythm Electrophysiol. 2012 Oct;5(5):906-12. doi: 10.1161/CIRCEP.112.972000. Epub 2012 Aug 23.

18.

Management of recalled implantable cardioverter-defibrillator leads at generator replacement: a decision analysis model for Fidelis leads.

Burri H, Combescure C.

Europace. 2014 Aug;16(8):1210-7. doi: 10.1093/europace/eut425. Epub 2014 Jan 26.

PMID:
24469434
19.

Passive-fixation lead failure rates and long-term patient mortality in subjects implanted with Sprint Fidelis electrodes.

Vollmann D, Woronowicz S, Kmiec L, Jung K, Zenker D, Seegers J, Sossalla S, Dorenkamp M, Sohns C, Lüthje L, Hasenfuss G, Zabel M.

Europace. 2014 Feb;16(2):258-64. doi: 10.1093/europace/eut185. Epub 2013 Jun 28.

PMID:
23813451
20.

Impact of implanted recalled sprint Fidelis lead on patient mortality.

Morrison TB, Friedman PA, Kallinen LM, Hodge DO, Crusan D, Kumar K, Hayes DL, Rea RF, Hauser RG.

J Am Coll Cardiol. 2011 Jul 12;58(3):278-83. doi: 10.1016/j.jacc.2011.03.027.

Supplemental Content

Support Center